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In the mouse embryo, the onset of zygotic transcription occurs at the end of the first cell cycle, upon completion of DNA
replication. We show that the nonhistone chromosomal protein HMG-I, whose translocation into the pronuclei of one-cell
embryos is linked to this first round of DNA synthesis, plays a critical role in the activation of zygotic transcription. Indeed,
microinjection of purified HMG-I results in a higher nuclear accumulation of the protein and triggers an earlier activation
of zygotic transcription, an effect which is abolished by the preincubation of the protein with a specific antibody directed
against its AT-hook DNA-binding motifs. Significantly, microinjection of this antibody also prevents the normal onset of
transcription in the embryo, suggesting that endogenous HMG-I is similarly involved in this process. Finally, microinjec-
tion of the exogenous protein modifies chromatin structure as measured by in situ accessibility to DNase I. We propose that
general chromosomal architectural factors such as HMG-I can modulate the accessibility of chromatin to specialized
regulatory factors, thereby promoting a transcriptionally competent state. © 2000 Academic Press
Key Words: colocalization software image analysis; early embryonic transcription; HMG-I; nuclear compartments; AT
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HMG-I/Y belongs to a subclass of the high-mobility-
group (HMG) proteins, a family of abundant low-molecular-
weight mammalian chromosomal proteins (Bustin and
Reeves, 1996). Three members of this subclass are known:
HMG-I; HMG-Y, which differs by a deletion of 11 amino
acids generated by alternative splicing of the HMG-I tran-
script; and HMG-IC, which is encoded by a distinct gene.
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All rights of reproduction in any form reserved.MG-I/Y and HMG-IC bind with high affinity to the minor
roove of AT-rich DNA, an interaction mediated by a
pecific DNA-binding domain, the “AT-hook,” which is
istinct from and unrelated to the “HMG box” present in
ther HMG proteins (Reeves and Nissen, 1990). HMG-I,
hich contains three tandem repetitions of the AT-hook
otif, was first isolated as a satellite-binding protein
Strauss and Varshavsky, 1984) and was later shown to bind
ithout specificity to any stretch of five to six dA z dT base
airs (Solomon et al., 1986). It has a particularly high
ffinity in vitro for the AT-rich sequences found in SARs/
ARs (scaffold or matrix-associated regions), from which it
s able to displace histone H1 (Zhao et al., 1993), and could
hus play a role in the modulation of chromatin structure
nd accessibility (Ka¨s et al., 1993). Indeed, MATH-20, an
artificial multi-AT-hook protein derived from HMG-I, has
been shown to suppress the variegation of a white gene337
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338 Beaujean et al.located close to AT-rich centromeric heterochromatin in
Drosophila (Girard et al., 1998). This activity is consistent
ith the hypothesis that proteins related to HMG-I can
ffect changes in chromatin structure and, in this case,
ffect the functional properties of heterochromatin.
HMG-I is involved in the transcriptional regulation of
pecific genes, such as the a-chain of the interleukin-2 (IL-2)
receptor (John et al., 1995) and the IL-4 (Klein-Hessling et
al., 1996), human interferon b (Thanos and Maniatis, 1992;
Yie et al., 1997), and germ-line e heavy-chain immuno-
lobulin (Kim et al., 1995) genes; it is also required for the
activity of the herpes simplex virus latency-active promoter
2 (French et al., 1996). In all these cases, HMG-I could exert
its biological function(s) through both binding-induced
structural modifications of DNA and direct protein/protein
interactions. More generally, HMG-I seems to play the role
of an “architectural transcriptional factor” as it seems to
bind with high affinity to noncanonical and/or distorted
DNA structures and can influence DNA bending (Nissen
and Reeves, 1995; Reeves and Wolffe, 1996); these proper-
ties might be utilized to facilitate the assembly of multi-
protein complexes (“enhanceosomes”) onto specific DNA
sequences (Falvo et al., 1995; Thanos and Maniatis, 1995).
Several studies have shown that HMG-I is specifically
expressed at high levels in rapidly proliferating cells that are
either normal or malignant (Johnson et al., 1990; Chiap-
petta et al., 1996; Vartiainen et al., 1988; Giancotti et al.,
1989). However, the correlation between high levels of
expression and cellular proliferation with any well-defined
biological function of the protein, and the extent to which
any such function depends on the DNA-binding properties
of HMG-I, remains unclear at present. One important clue
to a possible role of this family of proteins comes from
studies of pygmy mice: the loss of function of the HMG-IC
gene results in adult homozygous mutant mice markedly
smaller than normal, a phenotype which appears related to
a significant decrease in the rate of cellular proliferation
(Zhou et al., 1995), suggesting a general role for HMG-I in
the control of gene expression.
While the gene-specific roles of HMG-I/Y have previously
been studied in tissue culture cells or in ex vivo systems,
early embryonic development, in which the transition from
a transcriptionally inactive to an active state is part of a
tightly regulated program, provides a model system in
which a more general role might be assayed directly in
individual cells. In very early preimplantation stages, one-
to eight-cell mouse embryos are characterized, in addition
to their totipotent character, by a programmed regulation of
polymerase II-dependent transcriptional activity. After a
period of inactivity, transcription resumes at the end of the
first cell cycle in an unregulated manner (Latham et al.,
1992; Christians et al., 1995; Bouniol et al., 1995), the need
for specific transcriptional enhancers appearing only after
the first cleavage division (Martinez-Salas et al., 1989;
Wiekowski et al., 1991). This pattern of transcriptional
activation might reflect the ordered modification of chro-
matin structure by a limited number of effector proteinsCopyright © 2000 by Academic Press. All right(Worrad et al., 1995; Wiekowski et al., 1997). The implica-
tion of HMG-I in general as well as gene-specific transcrip-
tional regulation (see above) suggests that it might play a
similar role in the activation of zygotic transcription in the
embryo.
A previous study by Thompson et al. (1995) showed a
punctate nuclear distribution of HMG-I throughout the
first cell cycles of early mouse embryos, with HMG-I
mRNA levels decreasing dramatically at the eight-cell
stage. The localization of the protein and the variations in
its expression levels suggest that it might play a role in the
modifications of chromatin structure that most likely pre-
cede or accompany early events in embryogenesis. We
recently showed that, in different human and mouse cell
lines, HMG-I is distributed in three nuclear subpopulations
that differ in their susceptibility to nuclease digestion and
in situ competition by Hoechst 33342 (Amirand et al.,
1998). We proposed that these characteristics might be
related to the association of HMG-I with distinct regions of
chromatin, further suggesting a role for the protein in the
modulation of chromatin structure and function.
We have now addressed this question in more detail by
focusing on the possible involvement of HMG-I in the
establishment of a transcriptionally competent chromatin
conformation in one-cell mouse embryos. We find that the
nuclear translocation of endogenous HMG-I is temporally
regulated and depends on the initiation of the first round of
zygotic DNA replication. Results described below show
that it is possible to alter selectively the timing of the onset
of zygotic transcription by modulating the nuclear concen-
tration of HMG-I and/or its DNA binding capacity. Con-
versely, microinjection of histone H1, which competes
with HMG-I for binding to AT-rich DNA (Ka¨s et al., 1993;
hao et al., 1993), has an inhibitory effect on zygotic
ranscription. These results are the first describing a general
ole for HMG-I in the activation of transcription in vivo, an
ctivity that might be linked to the displacement of one or
everal factors interacting with AT-rich sequences, thereby
romoting a transcriptionally competent state.
MATERIALS AND METHODS
Collection of Oocytes and Embryos
Ovarian oocytes at the germinal vesicle (GV) stage were col-
lected from 4-week-old C57/CBA mice as already described (Debey
et al., 1993) and cultured at 37°C, under paraffin oil, in M2 medium
supplemented with dibutyryl cyclic AMP (100 mg/ml) to prevent
pontaneous meiotic maturation. Superovulation was induced in
57/CBA female mice by injection of pregnant mare serum gonad-
tropin (Intervet, France), followed 48 h later by injection of human
horionic gonadotropin (hCG; Intervet). Females were then mated
ith C57/CBA males. Mating was assessed by the presence of plugs
7 h after hCG injection (hphCG). One-cell embryos were then
ollected and cultured in Whitten’s medium as previously de-
cribed (Bouniol-Baly et al., 1997). To take into account the
synchrony of fertilization, all experimental lots contained em-
ryos collected from three to five mice. Two- to eight-cell embryoss of reproduction in any form reserved.
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339Early Induction of Transcription by HMG-Iwere obtained from one-cell embryos cultured in vitro. In experi-
ments in which two-cell embryos had to be analyzed just after the
first cleavage, one-cell embryos were checked every 30 min be-
tween 28 and 33 hphCG. Those undergoing the first cleavage
division were selected and cultured in Whitten’s medium for 15 to
60 min before being fixed and processed for immunolabeling.
HMG-I Protein, AT-Hook Peptide, and Antibodies
Recombinant human HMG-I protein was produced in Esche-
richia coli and purified by HPLC (Elton and Reeves, 1986). An
18-mer AT-hook peptide (Reeves and Nissen, 1990), ATX, was
synthesized and purified by HPLC. Its sequence (YGRPKKPRGRP-
KKGRPKK, 2.1 kDa) corresponds to a consensus AT-hook sequence
flanked by repetitions of the GRP core motif. An aliquot of the
peptide was coupled to ovalbumin (OVA) via the N-terminal
tyrosine to yield the hapten-carrier conjugate used to raise anti-
ATX antibodies. Polyclonal antibodies against HMG-I and the
AT-hook were obtained from rabbits immunized with purified
HMG-I or ATX-OVA, respectively (Eurogentec). High-titer serum
fractions were affinity purified against HMG-I protein bound to
activated CNBr-Sepharose (Pharmacia). Eluted fractions were
tested by Western blotting and those that reacted specifically with
HMG-I in extracts prepared from whole HeLa cells were pooled and
used in our experiments. The identity of cross-reacting material as
HMG-I/Y was confirmed by electrophoresis on acid/urea gels
alongside purified recombinant HMG-I, HMG-Y, HMG-14,
HMG17, and HMG-1 proteins, followed by Western blotting.
Western blots were performed according to standard procedures.
For the depletion experiments shown in Fig. 1B, the serum was
incubated with the samples in the absence or presence of purified
HMG-I protein.
In Vitro HMG-I/DNA Binding Experiments
Gel-shift experiments were performed using purified HMG-I
protein and a 657-bp DNA fragment corresponding to the SAR
region located in the Drosophila histone gene repeat that binds
HMG-I highly selectively (Zhao et al., 1993). Twenty-five-
microliter reactions containing about 20,000 cpm (2 ng) labeled
DNA and 250 ng salmon sperm competitor DNA in binding buffer
(10 mM Tris–HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 5%
glycerol) were incubated with 2.5–25 ng purified protein for 20 min
at room temperature before loading on a 6% acrylamide gel in
0.253 TBE buffer. After electrophoresis at 200 V for 18 h at 4°C
with buffer recirculation, the gel was dried and exposed. Preincu-
bation of the protein (25 ng) with antibodies (10 ng of affinity-
purified anti-HMG-I or 10 and 50 ng of anti-ATX) was performed
for 1 h at room temperature in 10 ml binding buffer. The antibody/
protein complexes were then mixed with labeled probe and com-
petitor DNA in a 25-ml final volume of binding buffer and treated
as above. Co-incubation experiments were performed by incubat-
ing DNA and protein (25 ng) in a 25-ml volume of binding buffer for
0 min at room temperature before addition of antibodies (10 ng of
nti-HMG-I or 10 and 50 ng of anti-ATX) and continued incubation
or an additional 20 min at room temperature. Here and below, the
ntibody amounts indicated correspond to IgG heavy and light
hains as quantitated by SDS–PAGE analysis of the sera followed
y silver staining.Copyright © 2000 by Academic Press. All rightMicroinjection of One-Cell Embryos
Embryos were microinjected in the cytoplasm with 1 6 0.5 pl of
the solutions described below, yielding an approximate dilution of
1/2000. All microinjections were performed on a Nikon inverted
microscope using Narishige micromanipulators and an Eppendorf
microinjector. To detect transcription sites, 100 mM BrUTP in 2
mM Pipes, pH 7.4, 140 mM KCl were microinjected. To analyze the
effect of HMG-I on the onset of transcription, HMG-I (70, 50, or 30
mM initial concentrations) or the AT-hook peptide (800 or 80 mM)
ere comicroinjected with BrUTP (100 mM) in the same buffer. In
ome experiments, HMG-I was incubated before microinjection for
h at room temperature with the anti-ATX antibody at a weight
atio of 5/1 and then mixed with BrUTP to yield concentrations of
0 mM HMG-I and 100 mM BrUTP, respectively. In two separate
xperiments, the anti-ATX antibody (1.6 mg/ml) was comicroin-
ected with BrUTP as above. As a control, the preimmune serum
as comicroinjected with BrUTP under the same conditions. The
istone-like HU protein (a generous gift from J. Rouvie`re-Yaniv,
RA CNRS 1139, Paris) and histone H1 (Boehringer Mannheim)
ere similarly comicroinjected with BrUTP at initial concentra-
ions of 88 and 70 mM, respectively. All microinjections were
performed at 19–20 hphCG and all experiments included a control
set of embryos microinjected with BrUTP alone at the same time.
Incubation of embryos was then continued in Whitten’s culture
medium until fixation.
Drug Treatments
To block protein synthesis, embryos were collected and cultured
in the presence of cycloheximide (10 mg/ml) or puromycin (20
mg/ml). To prevent DNA replication, embryos were cultured in the
presence of aphidicolin (4 mg/ml) until fixation. To block RNA
polymerase II (Pol II)-dependent transcription, embryos were col-
lected and cultured in the presence of a-amanitin (10 mg/ml). In this
case, a-amanitin (50 mg/ml) was also included in the injection
buffer (intracellular concentration of 25 6 12.5 ng/ml). These
treatments did not give rise to any detectable lethality over the
time course of the experiments.
Immunocytochemistry
Oocytes and embryos were fixed with 2% paraformaldehyde in
phosphate-buffered saline (PBS) for 20 min at room temperature,
permeabilized with 0.2% Triton X-100 (15 min), and then blocked
for 1 h in PBS containing 2% bovine serum albumin (BSA).
Incubation with the primary antibodies was allowed to proceed
overnight at 4°C before two washes with PBS (5 min each) and
incubation with the secondary antibody (1 h, room temperature).
Chromatin was then stained for 20 min with either propidium
iodide (50 mg/ml) followed by a ribonuclease A treatment (400
mg/ml, 30 min at 37°C) or 2 mg/ml Hoechst 33342. For fluorescence
bservation, oocytes and embryos were mounted on glass micro-
cope slides in Citifluor (Citifluor Company). Transcription sites
ere detected with a monoclonal mouse anti-BrdU antibody which
lso recognizes BrU (IgG, Caltag Laboratories, 1:400 dilution), using
fluorescein (FITC)-conjugated donkey anti-mouse secondary an-
ibody (IgG(H1L); Jackson ImmunoResearch Laboratories; 1:500
ilution). HMG-I was detected with the specific anti-HMG-I rabbit
olyclonal serum purified as described above (1:100 dilution), using
lissamine–rhodamine- or FITC-conjugated donkey anti-rabbit
econdary antibody (IgG(H1L); Jackson ImmunoResearch Labora-
ories; 1:100 dilution). Depletion of the anti-HMG-I antibody withs of reproduction in any form reserved.
340 Beaujean et al.the purified protein (Fig. 2B) was performed as described (Amirand
et al., 1998), except that centrifugation was for 1 h. For double
immunostaining, oocytes and embryos were incubated with anti-
bodies mixed together at the same final dilutions as above.
Micrococcal Nuclease Treatment
Micrococcal nuclease (MNase; Sigma Chemical; N 5386) was
prepared freshly before use in PBS containing 1 mM CaCl2. After
fixation and permeabilization, embryos were rinsed in PBS for 10
min and treated for 30 min at 37°C with different concentrations of
enzyme. DNA digestion was stopped by incubating embryos for 10
min at 4°C in PBS containing 20 mM EDTA.
Fluorescence Detection of DNase I Digestion Sites
Embryos microinjected with the HMG-I and HU proteins, with
the ATX peptide, or with dilution buffer alone (2 mM Pipes, pH 7.4,
140 mM KCl) were fixed, permeabilized, and kept at 4°C overnight
in PBS containing 2% BSA. After a 15-min incubation in digestion
buffer (40 mM Tris–HCl, pH 7.9, 10 mM NaCl, 6 mM MgCl2 and 10
mM CaCl2), embryos were treated for 5 min with 0.05 mg/ml
deoxyribonuclease I (DNase I; Amersham Life Science). They were
then washed once with water (5 min) and twice with PBS (10 min
each). In situ 39-end labeling reactions were performed for 1 h at
37°C in 25 ml of 13 terminal deoxynucleotide transferase (TdT)
reaction buffer (0.2 M potassium cacodylate, 25 mM Tris–HCl, pH
6.6, 0.25 mg/ml of BSA) containing 2.5 mM CoCl2, 100 mM BrdUTP
(Sigma) and 12.5 units of TdT (Boehringer Mannheim). Reactions
were stopped by incubating the embryos in 23 SSC for 15 min at
room temperature, followed by two washes in PBS (20 min each).
For immunodetection of BrdU incorporation sites, embryos were
blocked for 1 h in PBS containing 2% BSA before incubation with
the monoclonal mouse anti-BrdU antibody (1 h at room tempera-
ture, 1:100 dilution). Subsequent steps were performed as described
above except that the FITC-conjugated donkey anti-mouse second-
ary antibody was used at a 1:100 dilution.
Image Capture and Analysis
Fluorescence microscopy was performed on a Zeiss inverted
microscope (Axiovert 35), using a filter wheel equipped with
standard filters for FITC, rhodamine, and Hoechst emissions.
Images were captured through a Zeiss plan Neofluor 3100 (NA 1.3)
oil-immersion objective by a cooled CCD camera (Photometrics
Type KAF 1400, 12-bit dynamic range) coupled to the IPLAB
Spectrum imaging software (Amirand et al., 1998). A Zeiss 320
objective (NA 0.5) was used for quantification of total pronuclear
fluorescence intensities. Confocal microscopy was performed on
an upright Nikon microscope equipped with the Bio-Rad Laser-
Sharp MRC-1024 confocal laser scanning software, using a Nikon
Fluor 1003 (NA 1.3) oil-immersion objective and the 488- and
568-nm excitation wavelengths of the laser. The colocalization
image analysis software (SPIMAC) developed in our laboratory
(Amirand et al., 1998) was used to analyze in more detail the spatial
relationship between HMG-I, chromatin, and transcription sites.
Briefly, from two images of the same cell taken at two different
wavelengths, SPIMAC constructs a 2D histogram in which x and y
coordinates represent the gray levels of the same pixel in the two
images. Signal intensities are normalized by setting the highest x
and y values in each image to 100. A color associated with each
point of the 2D histogram represents the number of pixels with theCopyright © 2000 by Academic Press. All rightsame gray levels. Subpopulations appearing on the 2D histogram
can then be selected and interactively localized on the respective
original images. In addition, the software measures the number of
pixels of a given population and their relative contribution to the
fluorescence intensity.
RESULTS
In order to monitor the nuclear localization of HMG-I and
to analyze its possible role in early embryonic development,
we first raised rabbit polyclonal sera against the human
recombinant HMG-I protein and selected affinity-purified
fractions suitable for immunolocalization studies (Amirand
et al., 1998). Western blots of total HeLa nuclei show that
these antibody fractions react highly specifically with hu-
man HMG-I (Fig. 1A, lanes 1–3). They also react specifi-
cally, but less tightly, with an unknown 120-kDa protein
(Fig. 1A, compare lanes 1 and 2, which correspond to a
fivefold difference in serum dilution). This polyclonal se-
rum also cross-reacts with HMG-I in mouse extracts with a
similar specificity (data not shown).
We verified the specificity of the serum for HMG-I by
performing the depletion experiment shown in Fig. 1B.
Western blots were performed against HeLa nuclear ex-
tracts and purified HMG-I protein as described above,
except that incubation with the serum was performed in
the absence or presence of increasing concentrations of
purified HMG-I protein. Comparison of the controls in
lanes 1 and 2 (no depletion) with lanes 3–6 (depletion with
increasing amounts of purified protein) shows that reaction
of the depleted serum with HMG-I present in HeLa nuclei is
selectively abolished relative to p120. These results dem-
onstrate that the serum raised against HMG-I is specific for
that protein and that the limited cross-reactivity observed
with p120 is most likely due to recognition of a distinct
epitope absent in HMG-I.
We also raised an antibody against ATX, a synthetic
peptide corresponding to the AT-hook DNA-binding do-
main of HMG-I (Reeves and Nissen, 1990). Western blots of
HeLa nuclei using an affinity-purified fraction of the anti-
ATX serum are shown in Fig. 1A, lanes 4–6. By this assay,
anti-ATX has a selectivity identical to that of anti-HMG-I
and, at lower dilutions, also cross-reacts with the 120-kDa
band, which must therefore correspond to a novel human
AT-hook-containing protein. Anti-ATX is indeed highly
specific for the AT-hooks of the HMG-I protein. Gel-shift
experiments can be used to demonstrate the selective
binding of HMG-I to a DNA fragment containing a SAR
(Fig. 1C, lanes 2–6). This binding was diminished by prein-
cubation of anti-ATX with HMG-I prior to addition of the
SAR DNA (lanes 7 and 8). By comparison to the ladders
generated by incubation of the DNA with different
amounts of HMG-I, one can estimate that binding was
inhibited by about 50% at the highest antibody concentra-
tion tested (compare lanes 4 and 8). Higher amounts of
anti-ATX could not be used as they gave rise to smearing of
the DNA bands (see Fig. 1C, lane 10, in which DNA alones of reproduction in any form reserved.
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341Early Induction of Transcription by HMG-Iwas incubated with 100 ng anti-ATX before electrophore-
sis). In contrast, binding was not affected when HMG-I was
incubated with the SAR-containing DNA before addition of
the antibody (compare lanes 12 and 13 with lane 6). In
addition, no supershift could be observed under these con-
ditions, indicating that DNA-bound AT-hooks are no
longer accessible to anti-ATX, whereas the anti-HMG-I
serum could indeed induce a supershift of DNA/HMG-I
complexes when added before (lane 9) or after (lane 11)
incubation with DNA.
In summary, although they exhibit an identical selectiv-
ity in Western blots, our antibodies clearly recognize differ-
ent epitopes present in HMG-I. The serum directed against
HMG-I allows us to detect the protein whether bound to
DNA or not. Conversely, the anti-ATX antibody provides
us with the means to distinguish between free and DNA-
FIG. 1. Specificity of the anti HMG-I and anti-ATX sera. (A) Affi
Materials and Methods) were tested against total HeLa nuclei (
SDS–acrylamide gels. Increasing dilutions of the purified anti HMG
1024, respectively). The HMG-I and p120 signals were not detected
not shown). (B) The affinity-purified anti-HMG-I serum (1022 diluti
) and HeLa nuclear extracts (lanes 2, 4, and 6) in the presence of
oncentration in lanes 1 and 2, 3 and 4, and 5 and 6, respectively), re
ffect on the p120 band. (C) For gel-shift experiments, a 657-bp la
MG-I in the absence (lanes 2–6) or presence of affinity-purified a
gainst the full-length HMG-I protein (lanes 9 and 11). HMG-I con
5 (lane 5), and 25 ng HMG-I (lanes 6–9 and 11–13). Antibodies w
r after preincubation of HMG-I with DNA (lanes 11–13). Antib
nti-ATX or anti-HMG-I (lanes 7 and 9, respectively) or 50 ng of
espectively), or 50 ng of purified anti-ATX (lane 12). Lane 10 contaCopyright © 2000 by Academic Press. All rightound HMG-I protein and, in addition, is capable of inhib-
ting DNA binding by HMG-I.
Dynamic Distribution of HMG-I in Pronuclei of
One-Cell Embryos
While HMG-I has been shown to be present in the nuclei
of mouse oocytes and early embryos (Thompson et al.,
995; Amirand et al., 1998), its intranuclear localization has
ot been examined in detail during the first embryonic cell
ycle. As a role for HMG-I in early embryonic development
ight be reflected by changes in the distribution of the
rotein, we examined the localization of HMG-I in embryos
xed at various times after fertilization using the anti-
MG-I antibody described above. Up until 19 hphCG, no
ignal was detectable in the pronuclei of one-cell embryos
urified rabbit polyclonal sera raised against HMG-I and ATX (see
260 unit of whole nuclei per lane) electrophoresed on 7.5–15%
anti-ATX sera were used in lanes 1–3 and 4–6 (1022, 2 3 1023, 4 3
g the corresponding preimmune sera used at a 1:100 dilution (data
as tested as above against purified HMG-I protein (lanes 1, 3, and
asing concentrations of HMG-I protein (0, 0.5, and 2 mg/ml final
ng in the specific loss of the HMG-I signal. Depletion was without
SAR DNA fragment was incubated with increasing amounts of
odies raised against the ATX peptide (lanes 7–8 and 12 and 13) or
rations were 0 (lanes 1 and 10), 2.5 (lane 2), 5 (lane 3), 10 (lane 4),
cubated with 25 ng of HMG-I before addition of DNA (lanes 7–9)
were added in the following amounts: approximately 10 ng of
ATX (lane 8), 10 ng of anti-HMG-I or anti-ATX (lanes 11 and 13,
DNA alone incubated with 100 ng of the purified anti-ATX serum.nity-p
0.5 A
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342 Beaujean et al.(Fig. 2A, top row), even when the antibody concentration
was increased (data not shown). By 24 hphCG, HMG-I
immunolabeling was detectable in all embryos in the form
of small discrete dots of 0.3 mm average diameter, dispersed
throughout the nucleoplasm except for the area occupied by
the nucleolus-like bodies (NLBs; see Fig. 2A, second row).
These bright dots, which are clearly localized in regions of
low chromatin density indicated by arrows, represent only
FIG. 2. Nuclear distribution of endogenous HMG-I and chromat
oocytes were processed for immunodetection of HMG-I. DNA stain
right. (A) Conventional microscopy of one-cell embryos fixed at 19 o
in the pronuclei of 19-hphCG embryos. At 24 hphCG, HMG-I accu
relatively low chromatin density (arrows), superimposed over a di
chromatin ring is not labeled (arrowhead). (B) A similar experimen
protein (2 mg/ml final concentration) before immunolabeling. These
the HMG-I signal in Western blots of HeLa nuclei (Fig. 1B, lanes 4
images of ovarian GV oocytes with NSN or SN chromatin configu
Both types of oocytes are heavily labeled for HMG-I. In addition
condensed chromatin is also labeled (arrowheads). Bar, 10 mm. (D)
mbryos, each point represents the mean value of the percentage o
rror bars represent the standard errors between values obtained in d
abeling relative to the background observed at 19 hphCG (A, top
east four different experiments.Copyright © 2000 by Academic Press. All rightto 7% of the total nuclear fluorescence intensity and 2 to
% of the stained pixels (quantitative data provided from
he SPIMAC analysis of 14 embryos, see Materials and
ethods). They are superimposed over a diffuse staining
attern of lower intensity which accounts for most of the
mmunofluorescence signal.
As we were concerned that at least part of the labeling
ould be due to the p120 protein which cross-reacts with
one-cell mouse embryos and ovarian GV oocytes. Embryos and
s shown in the photographs on the left and HMG-I labeling on the
4 hphCG. DNA is labeled with Hoechst. HMG-I labeling is absent
tes in both pronuclei as discrete bright dots localized in regions of
staining pattern of lower intensity. The perinucleolar condensed
rformed with the HMG-I antibody depleted with purified HMG-I
ditions correspond to those that result in the specific extinction of
6). Embryos were fixed and processed at 24 hphCG. (C) Confocal
s (see Debey et al., 1993). DNA is labeled with propidium iodide.
mall dots dispersed in areas of low chromatin density (arrows),
e time course of HMG-I accumulation in the pronuclei of one-cell
G-I-labeled embryos averaged from results of several experiments.
ent experiments. Embryos are scored as positive for HMG-I nuclear
photograph). Each time point represents over 30 embryos from atin in
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343Early Induction of Transcription by HMG-Ithe anti-HMG-I antibody, we incubated the serum with
increasing concentrations of purified recombinant HMG-I
protein. Depletion of the serum led to the complete extinc-
tion of the signal at the highest protein/serum ratio tested
(Fig. 2B). This demonstrates that the immunostaining pat-
tern we observe indeed represents HMG-I labeling. Finally,
together with the results of the Western blots shown in Fig.
1B, these experiments establish that, despite a limited
cross-reactivity with the anti-HMG-I serum, there is no
contribution of p120 to the signal we observe in one-cell
embryos.
The punctate distribution of HMG-I and the relative
contribution of the dots to the overall staining pattern are
quite similar to those previously observed in mouse and
human cultured cell lines and in young mouse oocytes
(Amirand et al., 1998). The same labeling, indicated by
rrows, is also seen in both populations of fully grown
ocytes that can be distinguished at the GV stage before
vulation (Fig. 2C; see also Debey et al., 1993). In contrast,
he labeling of condensed chromatin found in oocytes could
ot be detected in one-cell embryos, particularly at the
eriphery of NLBs (see arrowheads in Figs. 2A and 2C).
inally, HMG-I could not be detected on metaphase chro-
osomes from the second meiotic metaphase to the fourth
mbryonic division. This is again different from the situa-
ion observed in somatic metaphases (Disney et al., 1989,
nd our unpublished observations).
We then tested whether the distinct subpopulations of
MG-I we detect in one-cell embryos are indeed associated
ith DNA. Digestion of one-cell embryos fixed at 24
phCG with 5 or 10 units/ml of MNase resulted in the loss
f the HMG-I signal in most of the embryos (92%, n 5 13,
nd 87%, n 5 15, respectively). Under these conditions,
hromatin could no longer be detected by Hoechst staining,
howing that it had been extensively digested (data not
hown). Therefore, the different populations of HMG-I we
etect in the pronuclei of one-cell embryos are most likely
NA-bound.
From 19 hphCG on, the proportion of embryos positive
or HMG-I labeling increases regularly with time, reaching
00% at 24 hphCG and remaining stable after that time to
he end of the first cell cycle (Fig. 2D). The HMG-I local-
zation pattern also persists throughout this interphase,
xcept that the number of HMG-I dots increases between
9 and 24 hphCG. This time-dependent increase in the
ccumulation of HMG-I in the pronuclei of one-cell em-
ryos might result from the translation of stored HMG-I
essenger RNAs or from a regulated translocation of
MG-I protein already present in the cytoplasm. To distin-
uish between these or other possibilities, we treated 19-
phCG embryos with 10 mg/ml cycloheximide or 10 mg/ml
uromycin for 5 h to inhibit protein synthesis. All treated
mbryos analyzed at 24 hphCG (n 5 12 for each drug)
isplayed detectable pronuclear HMG-I and the labeling
ntensity was not decreased by the presence of these inhibi-
ors (data not shown). Thus, the time-dependent accumu-
ation of HMG-I in pronuclei does not require de novoCopyright © 2000 by Academic Press. All rightprotein synthesis. In addition, the distribution of the dots
relative to the diffuse component was not changed by drug
treatment, as assessed by quantitative SPIMAC analysis of
13 treated embryos. This result, together with the fact that
HMG-I is present in nuclei of preovulatory oocytes, sug-
gests that, although not detected by immunofluorescence,
the protein is stored in the cytoplasm and that its translo-
cation in pronuclei is somehow regulated.
Interestingly, the earliest detection of HMG-I in pronu-
clei coincides with the beginning of the first round of DNA
replication at approximately 20–21 hphCG (Bouniol-Baly et
al., 1997). To determine whether the pronuclear accumula-
tion of HMG-I might be linked to this event, we cultured
embryos in the presence of 4 mg/ml aphidicolin. Remark-
ably, we could detect no HMG-I in the pronuclei of one-cell
embryos in which DNA synthesis was inhibited, at 24
hphCG (n 5 33) and as late as 27 hphCG (n 5 71), when
ll pronuclei from control embryos were labeled (Fig. 3).
his result strongly suggests that the localization of HMG-I
n pronuclei requires DNA replication.
We then asked whether a similar nuclear localization and
ime-dependence could be observed in subsequent cell
ycles. We selected embryos undergoing the first cleavage
ivision and cultured them in Whitten’s medium for be-
ween 15 and 60 min before fixing and processing them for
mmunolabeling. Their HMG-I labeling pattern was then
nalyzed as a function of the cleavage state, from anaphase
o complete reassembly of nuclei, as assessed by the pres-
nce of visible nucleoli. In two different experiments, none
f the embryos in anaphase of the first division (n 5 19)
ere labeled, while 40% of those in telophase (n 5 15) and
2% of those with reformed nuclei (n 5 66) showed nuclear
MG-I dots (data not shown). This indicates that, at the
wo-cell stage and in contrast to the results shown for
ne-cell embryos, HMG-I localizes to nuclei as soon as they
re formed and before the next S phase. Furthermore, in
wo- to eight-cell embryos, the HMG-I labeling pattern was
imilar to that seen at the one-cell stage, with discrete
ntense dots superimposed over a diffuse lower-intensity
taining pattern. HMG-I labeling over condensed chromatin
ould not be seen in these cases (data not shown).
Microinjection of Exogenous HMG-I Advances the
Onset of Transcription in One-Cell Embryos
The results presented above demonstrate that the nuclear
localization of HMG-I varies dynamically through the first
cell cycle, all embryos being positive for nuclear HMG-I at
24 hphCG. This is only a few hours before the activation of
transcription that occurs at 27 hphCG in the mouse
(Bouniol et al., 1995) and we next asked whether the timed
nuclear translocation of HMG-I might be linked to the
onset of transcription. HMG-I was already suggested to play
a role in establishing a more “open” chromatin structure
with an increased accessibility to the transcriptional ma-
chinery (Laemmli et al., 1992; Ka¨s et al., 1993; Zhao et al.,
993). According to this model, the regulated entry ofs of reproduction in any form reserved.
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344 Beaujean et al.FIG. 3. Inhibition of DNA synthesis prevents accumulation of HMG-I in the pronuclei of one-cell embryos. Control embryos are shown
in the first and third rows, one-cell embryos treated from the time of their collection on with 4 mg/ml aphidicolin (APH) in the second and
ourth rows. Samples were fixed and stained at 24 or at 27 hphCG. Images were captured in the focal plane of the male pronucleus. Hoechst
NA staining is shown in the photographs on the left, HMG-I labeling on the right. Treated embryos do not show any HMG-I labeling at
4 hphCG or as late as 27 hphCG, in contrast to controls fixed and stained at the same time. Bar, 10 mm.Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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345Early Induction of Transcription by HMG-IHMG-I into pronuclei could lead to an increase in chroma-
tin accessibility that precedes or signals the beginning of
transcription.
We therefore hypothesized that an earlier accumulation
of HMG-I in pronuclei might advance the onset of tran-
scription. To test this possibility, we microinjected HMG-I
FIG. 4. Early onset of transcription induced by microinjection of
or with 800 mM ATX at 19–20 hphCG. Photographs on the left sho
immunodetection of nuclear HMG-I; transcription sites detected b
at 25 hphCG in all cases. Control embryos microinjected with BrUT
embryos that were comicroinjected with BrUTP and 70, 50, or 30
able 1. Microinjection of the ATX peptide (800 mM) also activateCopyright © 2000 by Academic Press. All right70 mM initial concentration) in embryos at 19–20 hphCG
before endogenous HMG-I accumulates in pronuclei) to-
ether with BrUTP. The embryos were then fixed at se-
ected times after hCG injection, from 24 to 27 hphCG.
esults of these experiments are shown in Fig. 4 and
ummarized in Fig. 5A and Table 1. In contrast to the
-I. One-cell embryos were microinjected with 30–70 mM HMG-I
A staining by Hoechst 33342; photographs in the center show the
orporation of BrUTP are shown on the right. Embryos were fixed
ne are transcriptionally inactive at that time (top row), while some
MG-I are transcriptionally active, as summarized in Fig. 5A and
onset of transcription. Bar, 10 mm.HMG
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346 Beaujean et al.control population microinjected with BrUTP alone (n 5
133), which yielded no positive embryos at 25 hphCG and
in which transcription was first observed at 26 hphCG,
microinjection of HMG-I resulted in a significant fraction
(40%, n 5 134) of transcriptionally active embryos as early
as 25 hphCG, with the proportion of active embryos in-
creasing until 27 hphCG (Figs. 4 and 5A; Table 1). As
expected, microinjection of HMG-I led to more intense
pronuclear HMG-I immunolabeling than in controls micro-
injected with BrUTP alone. This is particularly evident in
regions of condensed chromatin such as the periphery of the
NLBs (compare the DNA and HMG-I images in the first two
rows of Fig. 4; see also Fig. 2A, second row). We verified that
the transcription detected in both microinjected and con-
FIG. 5. Specificity of the activation of transcription by HMG-I. Th
f embryos positive for BrUTP incorporation as a function of the
rUTP alone. Errors bars represent the standard errors between val
t 19–20 hphCG with BrUTP alone or with BrUTP plus HMG-I (70
nd scored for transcriptional activity. Statistical analysis of these
t 25 hphCG (P , 0.01). (B) Embryos were microinjected at 19–20
mM), HU (88 mM), or histone H1 (70 mM) and fixed at 25 or 27 hp
rUTP plus 70 mM HMG-I, with BrUTP plus HMG-I preincubated w
ntibody. Control embryos were microinjected with BrUTP alone. I
fter fixation at 25 or 27 hphCG, respectively. The corresponding saCopyright © 2000 by Academic Press. All rightrol embryos was indeed due to RNA Pol II activity since
ddition of a-amanitin resulted in the complete inhibition
of BrUTP incorporation (data not shown). Finally, microin-
jection of HMG-I alone did not disturb normal development
as 90% of microinjected and control embryos reached
blastocyst stage in vitro (n 5 30 for each).
Does this early activation of transcription require high
concentrations of exogenous HMG-I? To answer this ques-
tion, we chose to analyze embryos at 25 hphCG, when the
activating effect driven by HMG-I described above is readily
measurable as control embryos are never transcriptionally
active at that time (see above). Decreasing the initial
concentration of microinjected HMG-I did not change sig-
nificantly the percentage of embryos transcriptionally ac-
graphs presented in A and B show results expressed as a percentage
oinjected protein relative to control embryos microinjected with
btained in different experiments. (A) Embryos were microinjected
initial concentration), fixed at the times shown (23 to 27 hphCG),
ts was performed with the x2 test, the difference being significant
CG with BrUTP plus HMG-I (70 mM), the ATX peptide (800 or 80
. (C) One-cell embryos were microinjected at 19–20 hphCG with
the anti-ATX antibody, or with BrUTP together with the anti-ATX
nodetection of both HMG-I and transcription sites was performed
s are identified by the legends next to the photographs. Bar, 10 mm.e bar
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347Early Induction of Transcription by HMG-Itive at 25 hphCG (41%, n 5 34, and 38%, n 5 21, for
nitial HMG-I concentrations of 50 and 30 mM, respec-
tively; see Table 1). In parallel, the HMG-I staining of
condensed perinucleolar chromatin was abolished, al-
though the HMG-I signal, while decreasing as a function of
the concentration of microinjected protein, remained
higher than in controls. This suggests that the strong
accumulation of HMG-I in regions of condensed chromatin
observed at higher concentrations of the exogenous protein
bears little or no relation to the early activation of tran-
scription. Microinjection of HMG-I at initial concentra-
tions below 30 mM did not change the percentage of active
embryos relative to controls.
AT-Hook-Mediated DNA Binding Is Necessary for
the Early Activation of Transcription Driven
by HMG-I
The striking effect of an early accumulation of HMG-I in
pronuclei on the onset of transcription raises the question
of its specificity. If this effect is unique to HMG-I, other
DNA-binding proteins should have no effect on transcrip-
tion. To verify this, we microinjected, under the same
conditions, the bacterial HU protein which, in addition to
being comparable in size and charge to HMG-I, also shares
some of the general properties of HMG proteins (see Oberto
et al., 1994, for review). Only 1 (5%) of the 18 embryos
microinjected with HU was positive for transcription at 25
hphCG (Fig. 5B and Table 1), whereas none of the untreated
control embryos were positive. This small percentage of
active embryos observed after microinjection of HU was
TABLE 1
Transcriptional Activation in One-Cell Mouse Embryos
23 24
BrUTP (controls) 0% (n 5 20) 0% (n 5 52)
1HMG-I
70 mM 5%* (n 5 20) 4%* (n 5 27)
50 mM
30 mM
HU, 88 mM
ATX
800 mM
80 mM
HMG-I/a-ATX
a-ATX
1Preimmune serum
1H1, 70 mM
Note. BrUTP immunofluorescence results from 23 to 27 hphCG a
text. Results are expressed as percentages of embryos positive for B
in parentheses. The # symbol denotes values that are statistically d
0.005), while those that do not significantly differ are denoted by an
from the samples microinjected with HMG-I and analyzed at 25 hCopyright © 2000 by Academic Press. All righttatistically different from that obtained at the same time
fter microinjection of HMG-I (Table 1).
Another important question relating to the specificity of
he effect of HMG-I in one-cell embryos is whether it
equires DNA binding. If so, a similar advance in the onset
f transcription might be induced by microinjecting a
igand that interacts with DNA in the same way as HMG-I.
his is the case of the synthetic AT-hook (ATX) peptide,
hich recognizes in vitro the same AT-rich DNA se-
uences as HMG-I with an approximately 10-fold lower
ffinity (unpublished results). We microinjected the ATX
eptide at 19–20 hphCG at two different initial concentra-
ions, 800 and 80 mM, and transcription was again analyzed
t 25 hphCG. As shown in Figs. 4 and 5B and summarized
n Table 1, microinjection of the ATX peptide led, in both
ases, to an advance in the activation of transcription in
9% (n 5 66) and 40% (n 5 25) of the embryos, respec-
ively, an effect similar to that obtained after microinjec-
ion of full-length HMG-I. Thus, the DNA-binding proper-
ies of the AT-hook appear to be sufficient to advance the
nset of transcription. As our anti-HMG-I antibody does
ot recognize the ATX peptide, it is possible to examine the
ocalization of the endogenous nuclear HMG-I in these
mbryos. Interestingly, microinjection of the ATX peptide
id not modify the dot-like pattern of the endogenous
rotein (Fig. 4). As the effect of the ATX peptide is most
ikely exerted at sites that normally interact with endoge-
ous HMG-I, this result suggests that the population of
MG-I that corresponds to the intense dots does not play a
ajor role in transcriptional activation, in agreement with
Hours post-hCG
25 26 27
0% (n 5 133) 33% (n 5 24) 95% (n 5 79)
40%# (n 5 134) 48%* (n 5 65) 94%* (n 5 20)
41%# (n 5 34)
38%# (n 5 21)
5%§ (n 5 18)
39%# (n 5 66) 100%* (n 5 20)
40%# (n 5 25)
4%§ (n 5 51)
5%# (n 5 20)
100%* (n 5 15)
28%# (n 5 57)
mmarized for the different experimental conditions detailed in the
P incorporation at the times shown. Sample sizes (n) are indicated
nt from the corresponding controls assayed at the same time (P ,
isk (*). The § symbol indicates values that are statistically different
. Statistical analysis was performed using the x2 test.re su
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348 Beaujean et al.our previous findings in nuclei of HeLa or 3T3 cells
(Amirand et al., 1998).
A second prediction is that the effect of HMG-I on
ranscription should not be seen if the microinjected pro-
ein cannot interact with DNA and that the effect of
ndogenous HMG-I on transcription should be similarly
ensitive to the loss of DNA binding. We thus took advan-
age of our polyclonal antibody raised against the ATX
eptide. This antibody recognizes HMG-I highly effectively
n Western blots (see Fig. 1A, lanes 4–6), inhibits DNA
inding by HMG-I, but fails to recognize the DNA-bound
rotein (Fig. 1C). Indeed, microinjection at 19–20 hphCG of
he purified HMG-I preincubated with this antibody abol-
shed the activation of transcription by the exogenous
rotein: only 2 (4%) of the 51 embryos microinjected with
he protein/antibody complex were transcriptionally active
t 25 hphCG. Significantly, HMG-I immunostaining re-
urned to levels similar to those observed in control em-
ryos (Fig. 5C, compare the HMG-I images of the first and
hird rows).
We then examined the sensitivity of the endogenous
rotein to this antibody. At 19–20 hphCG, when essentially
o endogenous HMG-I is detected in the pronuclei and the
rotein is most likely in the cytoplasm (see Discussion), the
nti-ATX antibody might titrate the AT-hooks of endoge-
ous HMG-I as it does in vitro, resulting in a comparable
nhibitory effect. Indeed, in two experiments in which the
nti-ATX antibody was microinjected alone at 19–20
phCG, 19 (95%) of the 20 embryos analyzed were not
ranscribing at 27 hphCG (Fig. 5C and Table 1), while all the
ontrol embryos microinjected with BrUTP added to pre-
mmune serum were active by that time (Table 1). In
ddition, HMG-I immunolabeling was significantly de-
reased in these transcriptionally inactive embryos (see the
MG-I image in the bottom row of Fig. 5C). This shows
hat the interaction of the anti-ATX antibody with endog-
nous or exogenous HMG-I protein can suppress both the
ormal and the advanced onset of transcription, by inhib-
ting the DNA-binding capacity of HMG-I and/or by pre-
enting its nuclear accumulation. Alternatively, anti-ATX
ould exert these effects by interfering with other AT-hook-
ontaining proteins.
Microinjection of Somatic Histone H1 Inhibits the
Normal Onset of Transcription in One-Cell
Embryos
If DNA binding of HMG-I is important for transcriptional
activation, proteins that can compete with HMG-I for
binding to its genomic targets should have an effect similar
to that of the anti-ATX antibody, i.e., opposite to that of
HMG-I. Histone H1 has been shown to be able to compete
in vitro with HMG-I for binding to AT-rich DNA (Zhao et
al., 1993). Indeed, after microinjection of somatic histone
H1 (70 mM) together with BrUTP at 19–20 hphCG, only
8% (n 5 57) of the microinjected embryos were transcrip-
ionally active at 27 hphCG, in contrast to control embryosCopyright © 2000 by Academic Press. All righticroinjected with BrUTP alone (Figs. 5B and Table 1). This
esult is consistent with the hypothesis that the activation
f transcription by HMG-I could be effected by a redistri-
ution of the embryonic linker histone resulting from
pecific interactions between HMG-I and AT-rich regions
f the genome (Laemmli et al., 1992; Ka¨s et al., 1993; Zhao
t al., 1993). If this were the case, one would expect such a
isplacement to be reflected by general changes in chroma-
in structure and organization.
Microinjection of HMG-I Increases Accessibility of
Chromatin to DNase I
If HMG-I activates transcription by inducing changes in
chromatin structure, for instance by promoting “chromatin
opening” (Ka¨s et al., 1993), such an unfolding of the
chromatin fiber might be accompanied by detectable
changes in its accessibility to nucleases. To test this hy-
pothesis, we compared the overall sensitivity of pronuclear
chromatin to limited in situ digestion by DNase I in control
nd HMG-I-microinjected one-cell embryos. Cleavage sites
ere then mapped by immunofluorescence detection of
odified nucleotides (BrdU) incorporated by TdT in em-
ryos fixed at 22 or 25 hphCG. Confocal images of the
ignal detected in control and HMG-I-microinjected one-
ell embryos are shown in Fig. 6A. In both cases, DNase I
leavage sites are distributed fairly uniformly throughout
he nucleoplasm of the pronuclei. This distribution is
imilar to that previously observed in nuclei of highly
roliferating cells such as undifferentiated PC12 or malig-
ant glioma cells (Puck et al., 1991; Park and De Boni,
998). Significantly, microinjection of HMG-I (70 mM) at 19
hphCG markedly increased the average number of DNase I
cleavage sites in the pronuclei of most embryos relative to
controls (compare the two photographs in Fig. 6A). When
the overall nuclear fluorescence intensity was quantified
using a 203 objective (thus allowing collection of the
fluorescence signal emitted by the whole pronuclei), it was
found to be increased by an average of 40% in HMG-I-
microinjected embryos fixed either at 22 or at 25 hphCG, a
statistically significant difference (Fig. 6B; n $ 20 for each,
, 0.01). However, it is important to note that microin-
ection of HMG-I at a lower concentration (30 mM) and of
he ATX peptide (800 mM), although activating transcrip-
tion, did not lead to a significant increase in the overall
nuclear fluorescence intensity (data not shown and see
Discussion). Microinjection of HU (88 mM) under the same
conditions had no effect on the accessibility of chromatin to
DNase I.
Relationship between the Nuclear Distribution of
Endogenous HMG-I and Transcription Sites in
One-Cell Embryos
Because of the apparent relationship between HMG-I (or
AT-hook) nuclear content and transcriptional activation,
we asked whether HMG-I-rich sites might indeed corre-s of reproduction in any form reserved.
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349Early Induction of Transcription by HMG-Ispond to transcription sites. Using the SPIMAC colocaliza-
tion program (Amirand et al., 1998), we compared endoge-
ous HMG-I and BrUTP immunofluorescence images
FIG. 6. Microinjection of HMG-I affects DNase I sensitivity of
chromatin in one-cell embryos. In situ DNase I cleavage sites were
detected in embryos microinjected at 19–20 hphCG with dilution
buffer alone or with 70 mM HMG-I and fixed at 22 or 25 hphCG. (A)
onfocal images of the male pronucleus are shown for control and
MG-I-microinjected embryos fixed at 25 hphCG. Bar, 5 mm. (B) The
otal nuclear fluorescence intensities detected in control and HMG-
-microinjected embryos were quantified using a 203 objective.Copyright © 2000 by Academic Press. All rightbtained by confocal microscopy of embryos fixed at 27
phCG. The 2D histogram generated by SPIMAC (Fig. 7B)
hows that the population of pixels with high HMG-I
ontent (white frame) corresponding to the small intense
ots, which represent 3.4% of the stained pixels, and sites
f high BrUTP incorporation (red frame), which account for
.3% of the transcription signal, do not colocalize (compare
he SPIMAC images in Fig. 7A). In keeping with our
bservation that HMG-I dots are not displaced by microin-
ection of the ATX peptide (see Fig. 4), this result again
uggests that they most likely do not play a role in tran-
criptional activation. A broad correlation between the
ntensity of HMG-I labeling and of the BrUTP signal is,
owever, obvious for the rest of the pixels, which corre-
pond to the population of HMG-I revealed as a diffuse
taining pattern of lower intensity (Fig. 7B), a result similar
o that obtained in somatic cells (Amirand et al., 1998).
DISCUSSION
All of the known functions of HMG-I, an architectural
component of mammalian chromosomes, must be carried
out through DNA binding mediated by the AT-hook do-
mains of the protein. This sequence/structure recognition
motif interacts with a very broad family of potential bind-
ing sites as well as with specialized DNA structures. These
targets can be found in a variety of contexts: sequences
located in scaffold/matrix-associated regions, in different
satellite DNA repeats found in heterochromatin, in gener-
ally AT-rich boundary elements (Hart et al., 1997; Cuvier et
l., 1998), or dispersed in the genome next to gene-
egulatory regions, where they can be clustered or unique.
iven this very broad specificity for DNA binding, it is far
rom clear how specific functions might be carried out by
MG-I or related multi-AT-hook proteins. In some cases,
MG-I might act predominantly in general gene-regulatory
athways, while gene-specific functions might involve, in
ddition to DNA binding, specific interactions with direct
egulators.
While tissue culture or ex vivo systems have been widely
sed to analyze specific functions for HMG-I (see Introduc-
ion and references therein), the hypothetical role proposed
everal years ago for this protein as a general modulator of
hromatin structure (Laemmli et al., 1992) has not been
irectly studied. We chose to address this question using
he one-cell mouse embryo as a model system in which the
rst burst of transcription does not require specific tran-
cription factors or coactivators and thus most likely re-
ects a general genome-wide activation or derepression. In
his system, we show that nuclear accumulation of exog-
nous HMG-I advances the onset of transcription and that
nhibition of DNA binding by HMG-I leads to the loss of
ranscriptional activation. While the exact mechanism
hereby HMG-I activates transcription remains to be de-
ermined, our results are consistent with the hypothesis
hat one of the roles of HMG-I is to effect the modificationss of reproduction in any form reserved.
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350 Beaujean et al.of chromatin structure that most likely precede or accom-
pany the activation of transcription, possibly through its
interaction with the AT-rich SAR/MAR sequences (Zhao et
l., 1993) that have been implicated in general transcrip-
ional control in the preimplantation mouse embryo
Thompson et al., 1994).
Dynamic Localization of HMG-I in the Pronuclei of
One-Cell Embryos
Although highly abundant in preovulatory GV oocytes,
HMG-I cannot be detected by immunocytochemistry in
one-cell pronuclei before 20 hphCG, that is, approximately
8 h postfertilization. This is well after the formation of the
pronuclei, which takes place around 5 h postfertilization.
HMG-I behaves in this respect as several other nuclear
proteins, such as SC-35 (Vautier, 1994), snRNPs (Dean et
l., 1989; Vautier et al., 1994), hnRNP A (Ferreira et al.,
995), Sp1 and TBP (Worrad et al., 1994), or Pol II (Bellier et
l., 1997), which all concentrate only progressively in the
ronuclei of early embryos. The fact that de novo protein
synthesis is not required for the nuclear detection of HMG-I
indicates that the protein is present at fertilization, despite
the lack of detection on metaphase II chromosomes, and
that the time dependence of its nuclear immunodetection
FIG. 7. Nuclear localization of HMG-I and transcription sites. T
compared by SPIMAC analysis in one-cell embryos fixed at 2
(transcription) and HMG-I immunodetection in the female pronucl
the 2D histogram generated from the comparison of these two im
correspond to the points selected in the red frame on the 2D histogr
correspond to the points selected in the white frame on the 2D h
results. Bar, 5 mm.Copyright © 2000 by Academic Press. All rightat the one-cell stage reflects its nuclear translocation. When
not detected, we can suppose that HMG-I is too highly
diluted or lost due to detergent treatment. Finally, the effect
of depleting the anti-HMG-I serum with the purified pro-
tein shows that the immunofluorescence signal we detect is
indeed due to HMG-I and not to other AT-hook-bearing
proteins such as the p120 band which exhibits limited
cross-reactivity with our antibodies (Figs. 1B and 2B).
These particular kinetics of HMG-I nuclear localization
are specific to the first cell cycle, as we found the protein in
the nuclei of two-cell embryos as soon as they reform.
Taking into account the low molecular weight of the
protein (11.7 kDa), which in principle should allow its free
shuttling from the cytoplasm to the nucleus, several hy-
potheses can be proposed: this apparent initial cytoplasmic
retention could reflect a modification of transport mecha-
nisms in one-cell mouse embryos relative to later embry-
onic stages and somatic cells. Alternatively, the replication-
dependent accumulation of HMG-I in the nucleus could
result from the increased availability or unmasking of DNA
binding sites during S phase, resulting in a shift in the
equilibrium between cytoplasmic and nuclear HMG-I con-
centrations. Finally, HMG-I nuclear translocation could
require posttranslational modifications, such as phosphor-
ocalization of endogenous HMG-I and of transcription sites was
hCG after BrUTP microinjection. Confocal images of BrUTP
ere processed to yield the corresponding SPIMAC images (A) and
(B). The black pixels in the SPIMAC image of transcription sites
In the SPIMAC image of HMG-I localization sites, the black pixels
gram. SPIMAC analysis of the male pronucleus yielded identicalhe l
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351Early Induction of Transcription by HMG-Iylation, as already shown in the case of Pol II during the
first embryonic cell cycle (Bellier et al., 1997).
We also note that the nuclear distribution of HMG-I up to
the eight-cell stage differs from that found in somatic cells
or in GV oocytes, particularly through the absence of
labeling of condensed chromatin. These regions neverthe-
less became labeled when the cellular concentration of
HMG-I was increased through microinjection of the pro-
tein, in a process which clearly depends on the concentra-
tion of exogenously added HMG-I (see Fig. 4). This suggests
either that condensed chromatin of one-cell embryos has a
lower affinity for HMG-I or that HMG-I is less concentrated
in these cells than in the tissue-culture lines analyzed so
far. Indeed, we previously showed that, in cultured somatic
cells and in young mouse oocytes, the population of HMG-I
bound to condensed chromatin is the most easily displaced
by competition with Hoechst 33342, a minor groove-
specific ligand (Amirand et al., 1998). Another difference
ith observations made in somatic cells is the absence of
abeling of metaphase chromosomes, whether from MII
ocytes or from subsequent embryonic divisions.
The Accumulation of HMG-I in Pronuclei
Determines the Onset of Transcription
The most striking result of our studies is the 2-h advance
in the onset of transcription that can be induced in one-cell
embryos by increasing the cellular concentration of HMG-I.
This effect is specific, as it is not obtained with the bacterial
HU protein. It requires the binding of HMG-I to DNA, since
a similar advance is obtained by microinjection of the ATX
peptide, which corresponds to the DNA-binding domain of
the protein. Finally, this effect is abolished by preincuba-
tion of HMG-I with the anti-ATX antibody before microin-
jection. Similarly, microinjection of anti-ATX inhibits the
normal onset of transcription in one-cell embryos. These
results suggest that the transcription-activating effect of
HMG-I is linked to its DNA-binding activity, although we
cannot completely exclude that anti-ATX could exert its
inhibitory effect by retaining the protein in the cytoplasm
or by binding to other AT-hook-containing proteins. How-
ever, the strong effect of the anti-ATX antibody on HMG-I
labeling argues against this hypothesis and suggests that it
primarily interacts with the exogenously added or cytoplas-
mic endogenous HMG-I (Fig. 5C).
While we cannot, in this system, clearly distinguish
between an effect on specific and/or abundant transcripts
and a general mechanism affecting all transcription, it is
important to note the following: (1) the positive modulation
we observe reflects an all-or-none phenomenon and (2)
microinjection of our specific anti-ATX antibody leads to
the inhibition of transcription rather than a redistribution
of transcription sites. These results argue for a general—
rather than gene-specific—regulatory function. As a case in
point, the ATX peptide can also induce an early onset of
transcription. DNA binding by AT-hook motifs is thus
sufficient for transcriptional activation in the one-cellCopyright © 2000 by Academic Press. All rightouse embryo, whereas gene-specific activation by HMG-I
n somatic cells has been shown to require the presence of
omains other than the AT hooks (see for instance Yie et
l., 1997).
The ATX peptide, microinjected at concentrations that
ctivate transcription, does not change the dot-like local-
zation of the endogenous HMG-I protein, strongly suggest-
ng that it does not displace the protein from these sites. We
avor the interpretation that the intense dots do not repre-
ent sites where HMG-I exerts its activating effect on
ranscription, although they are located in regions of low
NA density. This is further confirmed by the SPIMAC
nalysis of the transcription sites relative to the distribu-
ion of the endogenous HMG-I protein, which shows that
egions of high HMG-I signal intensities do not correspond
o sites of high BrUTP incorporation (Fig. 7), while the
iffuse component of lower intensity shows a better corre-
ation with transcription sites. A similar result was already
btained in somatic cells (Amirand et al., 1998).
Microinjected HMG-I Modifies the Accessibility of
Chromatin to DNase I
What is the mechanism whereby HMG-I affects the onset
of transcription? Studies performed in Xenopus have shown
that the transcriptional block at the beginning of embryonic
life is essentially due to the general inhibitory effect of
histone H1 or H1-like proteins (Wolffe, 1989; Bouvet et al.,
1994). These proteins might play a similar role in the mouse
embryo. Lin and Clarke (1996) have shown that somatic
histone H1 is transported efficiently in the pronuclei of late
one-cell embryos when microinjected in the cytoplasm at
the beginning of the first cell cycle. Using the same experi-
mental conditions, we indeed found that the microinjection
of H1 inhibits the normal onset of transcription at 27
hphCG in more than 50% of the embryos. If histone H1 or
H1-like proteins were responsible, at least in part, for the
repression of transcription up to 27 hphCG, the activating
effect of HMG-I in one-cell mouse embryos could be medi-
ated by selective displacement of histone H1 or other
general repressors, rendering it accessible to the transcrip-
tion machinery (Laemmli et al., 1992; Ka¨s et al., 1993; Zhao
et al., 1993; Poljak et al., 1994).
If this were the case, one could expect that both the
ormal and the early onsets of transcription that require
MG-I would be accompanied by measurable changes in
hromatin structure. The results of our experiments based
n the in situ detection of chromatin regions accessible to
Nase I (Fig. 6) indeed support the idea that the effect of
MG-I on early zygotic transcription is mediated by mea-
urable changes in chromatin structure and/or accessibility.
owever, it is important to note that microinjected HMG-I
an enhance the DNase I-sensitivity of chromatin as early
s 22 hphCG, when no transcriptionally active embryos can
e detected, and affects practically all embryos at 25
phCG, when only 40% of them undergo advanced tran-
cription. These observations suggest that the changes ins of reproduction in any form reserved.
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jected HMG-I most likely precede the activation of tran-
scription.
Nevertheless, DNase I cleavage sites clearly preexist in
the pronuclei of one-cell embryos and microinjection of the
ATX peptide or of a lower HMG-I concentration, which
both induce an earlier onset of transcription (Fig. 4), does
not lead to a significant increase in the average DNase
sensitivity of chromatin. One possible explanation for this
behavior is that, in the latter cases, the increase in DNase I
sensitivity induced in each individual embryo is statisti-
cally too small to be distinguishable from the mean basal
level, given the natural asynchrony among embryos (see
Fig. 2D) and the inherent variability in the amount of
microinjected HMG-I. Finally, it is important to note that it
is difficult to determine whether the DNase cleavage sites
detected in situ correspond to specific hypersensitive sites
or to broader DNase I-sensitive chromatin regions. We are
currently investigating this important question.
We conclude from these studies that HMG-I is the first
chromosomal protein described so far that appears to be
required for general transcriptional activation and whose
presence in the nucleus can be shown to advance the onset
of transcription in one-cell mouse embryos. This activity
requires only DNA binding, suggesting that it is based on a
simple competition with other proteins that bind to the
same broad family of target sites, a result which bears on
how titration of highly reiterated AT-rich sequences might
play a critical role in early steps of transcriptional activa-
tion as well as in other aspects of genome dynamics (Strick
and Laemmli, 1995; Girard et al., 1998). This role might be
superseded by more specific functions as the concentration
of HMG-I protein decreases during development and differ-
entiation (Thompson et al., 1994). This experimental sys-
tem should prove useful to analyze in more detail the
precise relationships that exist between DNA synthesis,
nuclear import of HMG-I, and the onset of zygotic tran-
scription and how they correlate with the changes in
chromatin structure that precede or accompany these dif-
ferent events of early embryonic development.
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